Colestilan chloride
- Generic Name
- Colestilan chloride
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 95522-45-5
- Unique Ingredient Identifier
- VSI302RYSR
- Background
Colestilan is an ingredient in the EMA-withdrawn product BindRen.
- Associated Conditions
- Hyperphosphataemia
- Associated Therapies
- -
Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-11-06
- Last Posted Date
- 2017-05-12
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 18
- Registration Number
- NCT01976572
- Locations
- 🇬🇧
Covance Clinical Research Unit Ltd., Leeds, Springfield House Hyde Street, United Kingdom
Safety and Tolerability Study of MCI-196
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2013-03-26
- Last Posted Date
- 2015-05-27
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 4
- Registration Number
- NCT01818687
- Locations
- 🇬🇧
Investigational site, London, United Kingdom
Long-term Extension Study of MCI-196
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2013-03-20
- Last Posted Date
- 2015-05-27
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 6
- Registration Number
- NCT01814917
- Locations
- 🇬🇧
Investigational site, London, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath